ASX:AC8

AusCann Group Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume537,446 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive AC8 News and Ratings via Email

Sign-up to receive the latest news and ratings for AusCann Group and its competitors with MarketBeat's FREE daily newsletter.

About AusCann Group

AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.

AusCann Group Holdings Ltd.
July 29, 2021 | wsj.com

AusCann Commences Australian Product Registration with First Regulatory Filing for DermaCann®
July 19, 2021 | finance.yahoo.com

Is this why the AusCann Group Holdings Ltd (ASX:AC8) share price fell 14%?
June 9, 2021 | fool.com.au

AUSCANN GROUP HLDGS O.N. (UVP.BE)
March 16, 2021 | sg.finance.yahoo.com

AusCann Group Holdings Ltd. Reg (UVP.SG)
March 12, 2021 | sg.finance.yahoo.com

AusCann Group Holdings Ltd (AC8.AX)
December 17, 2020 | sg.finance.yahoo.com

Look out for the Auscann (ASX:AC8) and Cannpal (ASX:CP1) share prices post trading halt
November 16, 2020 | fool.com.au

Auscann (ASX:AC8) share price climbs higher on sale agreement
November 10, 2020 | fool.com.au

Is AusCann Group Holdings (ASX:AC8) In A Good Position To Invest In Growth?
October 21, 2020 | finance.yahoo.com

Is it time to buy into these three ASX cannabis shares?
September 18, 2020 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:AC8
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.auscann.com.au
Phone: 61 0 9561 8834
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $1.80 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 2.05
Book Value: A$0.10 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 23.37
Quick Ratio: 22.71

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.80 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for AusCann Group.

4.0 Community Rank

Outperform Votes
AusCann Group has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AusCann Group has received 12 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AusCann Group has received 60.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AusCann Group and other stocks. Vote “Outperform” if you believe AC8 will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AC8 will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
AusCann Group does not currently pay a dividend.
Dividend Growth
AusCann Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AusCann Group insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

AusCann Group (ASX:AC8) Frequently Asked Questions

What stocks does MarketBeat like better than AusCann Group?: Wall Street analysts have given AusCann Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AusCann Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are AusCann Group's key executives?: AusCann Group's management team includes the following people:
Mr. Layton Patrick Mills, Chief Exec. Officer
Mr. Charles Altshuler, CFO & Head of Supply
Ms. Susan Patricia Park FCIS, BCom, F Fin, ACA, AGIA, FFin, GAICD, ACIS, A, Joint Company Sec. (Age 46)
Who are some of AusCann Group's key competitors?: Some companies that are related to AusCann Group include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF), Charlotte's Web (CWBHF) and China Auto Logistics (CALI).
View all of AC8's competitors.
What other stocks do shareholders of AusCann Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AusCann Group investors own include Ardent Leisure Group Limited Stapled Securities (AAD), Cineworld Group (CINE), General Electric (GE), International Consolidated Airlines Group (IAG), Lloyds Banking Group (LLOY), Myer (MYR), Qantas Airways (QAN), Rolls-Royce (RR), Rackspace Technology (RXT) and Superdry (SDRY).
What is AusCann Group's stock symbol?: AusCann Group trades on the ASX under the ticker symbol "AC8."
How much money does AusCann Group make?: AusCann Group has a market capitalization of $0.00 and generates $1.80 million in revenue each year.
What is AusCann Group's official website?: The official website for AusCann Group is www.auscann.com.au.
How can I contact AusCann Group?: The company can be reached via phone at 61 0 9561 8834.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.